Generic Name: degarelix
Drug Class: Hormone Therapy Medications
Company: Ferring
Approval Status: Approved
Generic Version Available: No
Drug Indication
Firmagon is a GnRH receptor blocker approved for advanced prostate cancer.
General Info
Testosterone and other male hormones (androgens) stimulate prostate cancer growth. Gonadotropin-releasing hormone (GnRH) antagonists, also known as luteinizing hormone-releasing hormone (LHRH) antagonists, block signals in the brain that direct the testicles to produce testosterone. It lowers testosterone levels faster than GnRH agonist drugs like Zoladex (goserelin).
Dosage
Dosing Info:
Firmagon is given as a monthly subcutaenous injection.
Side Effects
Common side effects include injection site reactions, hot flashes, weight gain and liver enzyme elevations. Drugs that lower testosterone may lead to reduced sexual desire, erectile dysfunction and shrinkage of the testicles.
For More Info: https://firmagon.com/
Co-Pay Program Info: https://firmagon.com/
Patient Assistance Program Info: https://firmagon.com/
Last Reviewed: September 19, 2018
